SCHEMBL25435536

SCHEMBL25435536

CCOc1nccc(CNC2CC2)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
FLT3 P36888 1/20 0.35
TYRO3 Q06418 1/20 0.35
MERTK Q12866 1/20 0.35
GAS6 Q14393 1/20 0.35
KCNH2 Q12809 3/20 0.34
CSNK2A1 P68400 1/20 0.34
RXRA P19793 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
MAPK14 Q16539 1/20 0.33
NPBWR1 P48145 1/20 0.33
MCHR1 Q99705 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
HSD17B10 Q99714 1/20 0.33
IL6 P05231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12256540 0.75 MAPK8 (0.40) MAPK8RXRAGRIN1GRIN2BMAPT
SCHEMBL17601073 0.74 HTT (0.38) ALDH1A1KDM4EHPGDRAB9A
SCHEMBL30209653 0.74 PARP1 (0.40) ALDH1A1KDM4EMERTKKCNH2MAPT
Hydrochloric Acid SCHEMBL6582748 0.73 PRMT5 (0.40) FLT3TYRO3MERTKGAS6MAPK14
SCHEMBL16815492 0.72 RXRA (0.42) MAPK8RXRAGRIN1GRIN2BHPGD
SCHEMBL16854545 0.69 GLA (0.44)
SCHEMBL18166832 0.69 HRH4 (0.39) RXRAGRIN1GRIN2B
SCHEMBL24316207 0.68 TRPV3 (0.41) ALDH1A1KDM4EKCNH2
SCHEMBL20379405 0.66 CCNC (0.36) MAPK8CSNK2A1MAPK14
SCHEMBL27010653 0.66 TRPV3 (0.39) ALDH1A1KDM4EKCNH2RXRAGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295178-A1 SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS DART NEUROSCIENCE LLC (US) 2023-09-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230295178-A1 SUBSTITUTED FURANOPYRIMIDINE COMPOUNDS AS PDE1 INHIBITORS PDE4A, PDE5A, PDE3A MAPK8 2523/4885ALDH1A1 87/4885KDM4E 3280/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.